Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02611219 · ClinicalTrials.gov registry record · Early Phase 1

Deconditioning in Transplant

A Early Phase 1 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Early Phase 1
Development phase
30
Enrollment target

NCT02611219 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02611219, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Early Phase 1
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that deconditioning occurs rapidly over the course of the hospitalization post-transplant and can negatively impact quality of life. By encouraging patients to be out of bed for six hours each day, it is anticipated that patients will experience less deconditioning than those patients who previously had no established minimum time out of the bed.

Interventions

  • OTHER General Health Module-Baseline Adolescent-Self Report (13-18 years)
  • OTHER General Health Module-Follow Up Adolescent-Self Report (13-18 years)
  • OTHER General Health Module-Baseline Parent Report-Adolescent (13-18 years)
  • OTHER General Health Module-Follow Up Parent Report-Adolescent (13-18 years)
  • OTHER General Health Module-Baseline Parent Report-School Age (5-12 years)

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-03
Est. Completion 2016-04
Phase Early Phase 1

What the Registry Record Tells You About NCT02611219

The ClinicalTrials.gov registry entry for NCT02611219 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which General Health Module-Baseline Adolescent-Self Report (13-18 years) is the first listed.

NCT02611219 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02611219 about?

NCT02611219 is a clinical study titled "Deconditioning in Transplant". The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that d...

What is the current status of trial NCT02611219?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2015-03. Estimated completion is 2016-04.

What interventions are being tested in trial NCT02611219?

The interventions under investigation include: General Health Module-Baseline Adolescent-Self Report (13-18 years) (OTHER), General Health Module-Follow Up Adolescent-Self Report (13-18 years) (OTHER), General Health Module-Baseline Parent Report-Adolescent (13-18 years) (OTHER), General Health Module-Follow Up Parent Report-Adolescent (13-18 years) (OTHER), General Health Module-Baseline Parent Report-School Age (5-12 years) (OTHER).

Who is sponsoring clinical trial NCT02611219?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.